LGVN - Longeveron Inc. Stock Price, Fair Value and News

$1.65+0.05 (+3.13%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

LGVN Price Action

Last 7 days

-11.3%

Last 30 days

-10.8%

Last 90 days

-19.1%

Trailing 12 Months

-86.8%

LGVN RSI Chart

LGVN Valuation

Market Cap

22.5B

Price/Earnings (Trailing)

-1.3K

Price/Sales (Trailing)

12.1K

Price/Free Cashflow

-1.5K

LGVN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

LGVN Fundamentals

LGVN Revenue

Revenue (TTM)

1.9M

Rev. Growth (Yr)

415.33%

Rev. Growth (Qtr)

65.17%

LGVN Earnings

Earnings (TTM)

-17.9M

Earnings Growth (Yr)

13.45%

Earnings Growth (Qtr)

-29.48%

LGVN Profitability

Operating Margin

73.06%

Return on Equity

-69.92%

Return on Assets

-59.91%

Free Cashflow Yield

-0.07%

LGVN Investor Care

Shares Dilution (1Y)

545.67%

Diluted EPS (TTM)

-6.5

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	978.0K	1.2M	1.9M	0
2023	961.0K	1.1M	937.0K	709.0K
2022	1.3M	937.0K	970.0K	1.1M
2021	0	0	0	1.3M
2020	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Longeveron Inc.

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, an allogeneic medicinal signaling cell therapy product isolated from the bone marrow of young, healthy adult donors. It is conducting Phase 1, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.

CEO	Mr. Mohamed Wa'el Ahmed Hashad
WEBSITE	https://longeveron.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	19

Longeveron Inc. Frequently Asked Questions

What is the ticker symbol for Longeveron Inc.? What does LGVN stand for in stocks?

LGVN is the stock ticker symbol of Longeveron Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Longeveron Inc. (LGVN)?

As of Fri Dec 20 2024, market cap of Longeveron Inc. is 22.49 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LGVN stock?

You can check LGVN's fair value in chart for subscribers.

Is Longeveron Inc. a good stock to buy?

The fair value guage provides a quick view whether LGVN is over valued or under valued. Whether Longeveron Inc. is cheap or expensive depends on the assumptions which impact Longeveron Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LGVN.

What is Longeveron Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, LGVN's PE ratio (Price to Earnings) is -1254.93 and Price to Sales (PS) ratio is 12.14 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LGVN PE ratio will change depending on the future growth rate expectations of investors.